Jasper Therapeutics Inc (NASDAQ: JSPR) is -74.23% lower on its value in year-to-date trading and has touched a low of $5.34 and a high of $31.01 in the current 52-week trading range. The question becomes, what are the chances the stock will make a comeback and enjoy potential growth. Why not look at analysts view on what the future holds for the stock. The JSPR stock was last observed hovering at around $5.34 in the last trading session, with the day’s gains setting it 0.17%.
Currently trading at $5.51, the stock is -65.26% and -72.12% below its SMA20 and SMA50 respectively. However, with a daily trading volume of 0.72 million and changing 3.18% at the moment leaves the stock -73.67% off its SMA200. JSPR registered -48.21% loss for a year compared to 6-month gain of -73.66%. The firm has a 50-day simple moving average (SMA 50) of $19.7662 and a 200-day simple moving average (SMA200) of $20.927126.
The stock witnessed a -74.31% loss in the last 1 month and extending the period to 3 months gives it a -69.69%, and is -21.84% down over the last 5 days. If we measure the stock’s price variations over the week and the month, we find that the volatility rates stand at 10.60% over the week and 11.31% over the month.
Jasper Therapeutics Inc (JSPR) has around 45 employees, a market worth around $82.66M and $0.00M in sales. Distance from 52-week low is 3.18% and -82.23% from its 52-week high. The company has generated returns on investments over the last 12 months (-75.01%).
The EPS is expected to grow by 26.45% this year, but quarterly earnings will post 0.00% year-over-year. Quarterly sales are estimated to shrink 0.00% in year-over-year returns.
Jasper Therapeutics Inc (JSPR) Top Institutional Holders
114.0 institutions hold shares in Jasper Therapeutics Inc (JSPR), with institutional investors hold 100.15% of the company’s shares. The shares outstanding are 15.00M, and float is at 11.24M with Short Float at 20.62%. Institutions hold 98.87% of the Float.
Jasper Therapeutics Inc (JSPR) Insider Activity
The most recent transaction is an insider sale by Mahal Jeetinder Singh, the company’s Chief Operating Officer. SEC filings show that Mahal Jeetinder Singh sold 900 shares of the company’s common stock on Dec 12 ’24 at a price of $22.11 per share for a total of $19899.0. Following the sale, the insider now owns 25009.0 shares.
Still, SEC filings show that on Sep 12 ’24, Mahal Jeetinder Singh (Chief Operating Officer) disposed off 900 shares at an average price of $21.23 for $19104.0. The insider now directly holds 25,009 shares of Jasper Therapeutics Inc (JSPR).
